Intersect ENT Inc XENT

Intersect ENT Inc

Medical Devices

Healthcare

XENT

33.35 M shares

NASDAQ US

traded

12 May 2022

listed

yes

open

28.25

52 week high

28.24

high

28.25

52 week low

15.97

low

28.23

growth

56.54 %

previous Close

28.24

P/E ratio

market cap

940 M

div yield

0

usd

Mar 2022

qoq

revenue

21.58 M

202.36 %

net incoming

-28.80 M

68.40 %

eps

68.75 %

eps surprise

-150.00 %

net profit margin

-133.51 %

-565.00 %

operating incoming

-26.67 M

70.20 %

net change in cash

-13.70 M

31.88 %

cash on hand

25.59 M

-33.36 %

cost of revenue

7.69 M

-5.51 %